<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Hershman Ronnie -->
          <cik>0002086512</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0002029039</issuerCik>
        <issuerName>Nasus Pharma Ltd</issuerName>
        <issuerCusip>M7071P109</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>Yigal Alon 65,</com:street1>
          <com:city>Tel Aviv</com:city>
          <com:stateOrCountry>L3</com:stateOrCountry>
          <com:zipCode>6744317</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Dr. Ronnie Hershman</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>954205.00</soleVotingPower>
        <sharedVotingPower>429307.00</sharedVotingPower>
        <soleDispositivePower>954205.00</soleDispositivePower>
        <sharedDispositivePower>429307.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1383512.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>15.3</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(1) Consists of (i) 891,187 Ordinary Shares held by Hershman Holdings LLC, over which Dr. Hershman has sole voting and investment power; (ii) 429,307 Ordinary Shares held by Phoenix Solutions Ltd., of which Dr. Hershman is the controlling shareholder and may be deemed to share voting and investment power; and (iii) 63,018 Ordinary Shares issuable to Dr. Hershman upon the exercise of share options exercisable within 60 days.

(2) Based on 9,014,105 ordinary shares that the issuer has advised the Reporting Person were issued and outstanding as of September 30, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Hershman Holdings LLC</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>891187.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>891187.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>891187.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>9.9</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
      <comments>(1) Hershman Holdings LLC holds 891,187 ordinary shares. Dr. Ronnie Hershman, the managing member of Hershman Holdings LLC, has sole voting and dispositive power with respect to such shares.

(2) Based on 9,014,105 ordinary shares that the issuer has advised the Reporting Person were issued and outstanding as of September 30, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Nasus Pharma Ltd</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>Yigal Alon 65, Tel Aviv, 6744317, Israel.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Statement is filed on behalf of Dr. Ronnie Hershman, and Hershman Holdings, LLC.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The address of each of the Reporting Persons is:

c/o Nasus Pharma Ltd.
Yigal Alon 65,
Tel Aviv, 6744317, Israel</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Dr. Ronnie Hershman is a citizen of the United States. Hershman Holdings LLC is a limited liability company organized under the laws of the State of New York.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The information required by Item 4(a) is set forth in Rows 5 through 9 and 11 of the cover pages for each of the Reporting Persons and is incorporated herein by reference.

The percentage set forth in this Schedule 13G is based on 9,014,105 ordinary shares that the issuer has advised the Reporting Person were issued and outstanding as of September 30, 2025.

 Mr. Hershman holds (i) 891,187 Ordinary Shares held by Hershman Holdings LLC, over which Dr. Hershman, the managing member of Hershman Holdings LLC, has sole voting and investment power; (ii) 429,307 Ordinary Shares held by Phoenix Solutions Ltd., of which Dr. Hershman is the controlling shareholder and may be deemed to share voting and investment power; and (iii) 63,018 Ordinary Shares issuable to Dr. Hershman upon the exercise of share options exercisable within 60 days.</amountBeneficiallyOwned>
        <classPercent>15.3%
9.9%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <exhibitInfo>Exhibit 1: Joint Filing Agreement</exhibitInfo>
    <signatureInformation>
      <reportingPersonName>Dr. Ronnie Hershman</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Dr. Ronnie Hershman</signature>
        <title>Dr. Ronnie Hershman</title>
        <date>11/13/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Hershman Holdings LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Dr. Ronnie Hershman</signature>
        <title>Dr. Ronnie Hershman/Managing Member of Hershman Holdings, LLC</title>
        <date>11/13/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>

</edgarSubmission>
